Complete regression of choroidal metastasis secondary to non-small-cell lung cancer with intravitreal bevacizumab and oral erlotinib combination therapy. [electronic resource]
Producer: 20100114Description: 411-3 p. digitalISSN:- 1423-0267
- Administration, Oral
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Choroid Neoplasms -- drug therapy
- Drug Therapy, Combination
- Erlotinib Hydrochloride
- Female
- Humans
- Injections, Intraocular
- Lung Neoplasms -- pathology
- Middle Aged
- Protein Kinase Inhibitors -- administration & dosage
- Quinazolines -- administration & dosage
- Remission Induction
- Vitreous Body
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.